The Medicines and Healthcare products Regulatory Agency chair Sir Michael Rawlins has warned that insulin supply could be disrupted in the face of a ‘no-deal’ Brexit because the UK imports “every drop of it”.
Commenting, Chris Leslie MP, leading supporter of the People’s Vote campaign, said:
“This critical warning from the chair of the MHRA shows just how serious the prospect of a ‘no-deal’ would be for this country. Millions of patients rely on insulin every day, and the Commons voted in July to instruct the Prime Minister to stay in the EEA medicines regulatory network, but the Government seems intent on ignoring this. It is time she accepted there is no majority for ‘no deal’ on this.
“The consequences of a ‘no-deal’ Brexit for this country show why we need a People’s Vote on the final Brexit deal. Brexit is a big deal. But it is definitely not a done deal.”
Notes to Editors
“Millions of patients could be affected by 'no-deal' Brexit medicines shortages, says MHRA chief” – The Pharmaceutical Journalhttps://www.pharmaceutical-journal.com/news-and-analysis/news/millions-of-patients-could-be-affected-by-no-deal-brexit-medicines-shortages-says-mhra-chief/20205240.article